Itrizole and blood creatine phosphokinase increased Patient Reports February 13, 2012

Itrizole Side Effects Report #6129851-2
Itrizole side effect was reported by a Pharmacist from JAPAN on Mar 16, 2009. Male patient, 18 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, myoglobin blood increased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #6137189-2
Itrizole side effect was reported by a Pharmacist from JAPAN on Mar 19, 2009. Male patient, 18 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, myoglobin blood increased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #4823946-9
Itrizole side effect was reported by a Pharmacist from JAPAN on Oct 31, 2005. Male patient, 76 years of age, was diagnosed with nail tinea and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, depressed level of consciousness. Itrizole dosage: unknown. During the same period patient was treated with TIAPRIDE HYDROCHLORIDE, NILVADIPINE, ETHYL LOFLAZEPATE. Patient was hospitalized. Patient recovered.

Itrizole Side Effects Report #4842037-4
Itrizole side effect was reported by a Pharmacist from JAPAN on Nov 22, 2005. Male patient, 76 years of age, was diagnosed with nail tinea and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, depressed level of consciousness. Itrizole dosage: unknown. During the same period patient was treated with TIAPRIDE HYDROCHLORIDE, NILVADIPINE, ETHYL LOFLAZEPATE. Patient was hospitalized. Patient recovered.


Itrizole Side Effects Report #5487758-8
Itrizole side effect was reported by a Physician from JAPAN on Oct 05, 2007. Male patient, 37 years of age, was diagnosed with nail tinea and was treated with Itrizole. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #4735711-1
Itrizole side effect was reported by a Physician from JAPAN on July 25, 2005. Female patient, 69 years of age, was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Itrizole dosage: unknown. During the same period patient was treated with RISPERDAL, QUETIAPINE FUMARATE, HALOPERIDOL. Patient recovered.

Itrizole Side Effects Report #4763506-1
Itrizole side effect was reported by a Physician from JAPAN on Aug 30, 2005. Male patient, 56 years of age, was diagnosed with onychomycosis, hypertension, anxiety  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood creatine phosphokinase increased. Itrizole dosage: unknown. During the same period patient was treated with CANDESARTAN, ETIZOLAM. Patient recovered.

Itrizole Side Effects Report #4768534-8
Itrizole side effect was reported by a Physician from JAPAN on Sept 02, 2005. Male patient, 56 years of age, was diagnosed with onychomycosis, hypertension, anxiety  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood creatine phosphokinase increased. Itrizole dosage: unknown. During the same period patient was treated with CANDESARTAN, ETIZOLAM. Patient recovered.

Itrizole Side Effects Report #4673137-X
Itrizole side effect was reported by a Physician from on May 10, 2005. Male patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Itrizole dosage: unknown. Patient recovered.


Itrizole Side Effects Report #5765110-5
Itrizole side effect was reported by a Pharmacist from JAPAN on May 30, 2008. Male patient, 35 years of age, was diagnosed with sporotrichosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood potassium decreased, muscular weakness, myalgia, myopathy. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #5773843-X
Itrizole side effect was reported by a Pharmacist from JAPAN on June 06, 2008. Male patient, 35 years of age, was diagnosed with sporotrichosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood potassium decreased, muscular weakness, myalgia. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #4598680-3
Itrizole side effect was reported by a Physician from on Feb 22, 2005. Male patient, 29 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #4607503-5
Itrizole side effect was reported by a Physician from on Feb 28, 2005. Male patient, 29 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Itrizole dosage: unknown. Patient recovered.

Itrizole Side Effects Report #4633012-3
Itrizole side effect was reported by a Physician from on Mar 30, 2005. Male patient, 29 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Itrizole dosage: unknown. Patient recovered.